BioCentury
ARTICLE | Financial News

Agile adds $40M in series C

July 20, 2012 12:23 AM UTC

Agile Therapeutics Inc. (Princeton, N.J.) raised $40 million in a series C round led by new investor Aisling Capital. Existing investors Care Capital; Investor Growth Capital; ProQuest Investments; Kaiser Permanente Ventures; and Novitas Capital also participated. Aisling Capital's Andrew Schiff joined Agile's board. ...